trial

Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia

NCTId NCT04190004
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 30 (actual)
Sponsored by National Institute of Mental Health and Neuro Sciences, India
Primary completion 2018-11-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
30 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2018-01-01
Primary completion
2018-11-30
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Vasopressins

Sponsors

National Institute of Mental Health and Neuro Sciences, IndiaLead Sponsor

Sites

1 total
Bangalore, India

Facts & assertions

4 sourced
Enrollment
30
Phase
NA
Primary Completion Date
2018-11-30
Status
COMPLETED
relationships
The graph out of here
drug
Vasopressins
drug
lead_sponsor
National Institute of Mental Health and Neuro Sciences, India
company
indication
Schizophrenia
indication
Schizophrenia
indication